Similar articles

• [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].

  László A, Csalánosiné Németh M, Joó I, Kiss E, Havass Z, Szenohradszki P. László A, et al. Orv Hetil. 1986 May 11;127(19):1129-31. Orv Hetil. 1986. PMID: 3714258 Hungarian. No abstract available.
• Atherosclerosis in patients undergoing maintenance hemodialysis.

  Bagdade JD. Bagdade JD. Kidney Int Suppl. 1975 Feb;(3):370-2. Kidney Int Suppl. 1975. PMID: 169427 No abstract available.
• Does atherosclerosis caused by dialysis limit this treatment?

  Kindler J, Sieberth HG, Hahn R, Glöckner WM, Vlaho M, Pelzer R. Kindler J, et al. Proc Eur Dial Transplant Assoc. 1983;19:168-74. Proc Eur Dial Transplant Assoc. 1983. PMID: 6348734
• [Lipid metabolism abnormalities and atherosclerosis in patients on maintenance hemodialysis].

  Musiał J, Undas A, Sysło K. Musiał J, et al. Przegl Lek. 1994;51(6):264-7. Przegl Lek. 1994. PMID: 7938663 Review. Polish.
• [Metformin, lipids and atherosclerosis].

  Joffroy-Lavieuville M, Triadou N, Noel M. Joffroy-Lavieuville M, et al. Journ Annu Diabetol Hotel Dieu. 1984:361-6. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6399538 Review. French. No abstract available.